Sectors
Capabilities
Specialisms
Cetaphil, the UK’s #1 Dermatologist recommended skincare brand, which launched in 1947 for sensitive skin, has 75 years of heritage and this year it reaffirms its commitment to clinically-proven sensitive skincare with the launch of new and improved formulas that advance the science behind the legacy brand.
The communications programme will aim to educate consumers on the five signs of sensitive skin, helping people to become more aware of the condition and empower them to manage the physical and psychological burden.
Running alongside Cetaphil, the teenage acne treatment Acnecide, known for addressing the real cause of acne, will be supported by an honest ‘truth telling’ campaign, which aims to dispel myths around causes and solutions for acne. This will be accompanied by a new launch from the brand later this year.
Both campaigns will include a robust press office as well as influencer and expert engagement to help educate consumers on effective skincare routines, as well as driving broader awareness and profile for the brands.
“The year ahead has many exciting and high profile moments for both Cetaphil and Acnecide as we continue to advance our skincare story and we’re delighted to be working with Brands2Life to ensure our brands are well known and understood. The team’s ambition, creativity and media expertise set them apart and we’re looking forward to seeing the plans come to life.”
“Galderma’s legacy and expertise in developing premium skin care products is truly impressive and we’re thrilled to be working together. For people with sensitive or acne prone skin, having the right skin care product can be transformative, so building consumer awareness and skin understanding will be at the heart of our work.”
Brands2Life’s award-winning Health & Wellbeing practice has a strong portfolio in consumer health including OTC, contraception, probiotics, eye care and mental health.
See all